ImmuneWalk Therapeutics is committed to developing novel therapies for chronic inflammatory diseases.
ImmuneWalk Therapeutics has raised $7.0M in total funding. The most recent round was Seed. The last funding was announced in May 2025.
ImmuneWalk Therapeutics is headquartered in Pearl River, United States.
ImmuneWalk Therapeutics is committed to developing novel therapies for chronic inflammatory diseases.
ImmuneWalk Therapeutics is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"ImmuneWalk Therapeutics — Funding & Investors." VCBacked, May 7, 2025, https://www.vcbacked.co/company/immunewalk-therapeutics. Accessed October 2, 2026.
VCBacked. (2025). ImmuneWalk Therapeutics — Funding & Investors. Retrieved October 2, 2026, from https://www.vcbacked.co/company/immunewalk-therapeutics
{{cite web |title=ImmuneWalk Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/immunewalk-therapeutics |website=VCBacked |access-date=October 2, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated